Data / Federal awards / NAICS 325412 / PINE PHARMACEUTICALS LLC
PINE PHARMACEUTICALS LLC: 24 federal contract awards, $1.3 million obligated (FY2024 to FY2027)
PINE PHARMACEUTICALS LLC (UEI TCJXKNYD6WL5), Tonawanda, NY, received 24 federal prime contract awards with $1.3 million obligated in fiscal years 2024 to 2027, from 2 agencies under 4 NAICS codes. Its largest buyer is Department of Health and Human Services ($1.2 million) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- TCJXKNYD6WL5UEI
- Tonawanda, NYLocation
- Small BusinessBusiness size
- 24Contract awards
- $1.3 millionObligated
- 2024-02-07First action in window
- 2026-08-20Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | 19 | $996,820 |
| 325199 | All Other Basic Organic Chemical Manufacturing | 1 | $125,813 |
| 339112 | Surgical and Medical Instrument Manufacturing | 1 | $121,989 |
| 325414 | Biological Product (except Diagnostic) Manufacturing | 3 | $13,408 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 20 | $1.2 million |
| Department of Veterans Affairs | 4 | $96,506 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $180,189 |
| FY2025 | $448,902 |
| FY2026 | $628,939 |
Contract awards
All 24 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N98026F00003 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK: STABLE ISOTOPES DEUTERIUM OXIDE (D, 70%), GLYCEROL (D5 GLYCEROL), AND GLUCOSE (6,6 DEUTERATED GLUCOSE) | $410,843 | $410,843 | July 8, 2026 | September 30, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94025F00001 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK: SERVICE: METABOLIC ISOTOPES: NON-SEVERABLE | $158,878 | $158,878 | April 14, 2025 | April 13, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94024P00696 | Department of Health and Human Services | Purchase Order | 325199 | NIDDK: SEVERABLE - ACQUISITION OF INTRAVENOUS STABLE ISOTOPES | $125,813 | $125,813 | September 16, 2024 | September 15, 2025 | Tonawanda, NY | usaspending.gov |
| 75N98025P01559 | Department of Health and Human Services | Purchase Order | 339112 | PINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFORMITY OF DRUG FORMULATION, EXCIPIENT COMPOSITION, APPEARANCE, | $121,989 | $121,989 | June 20, 2025 | January 31, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94026F00001 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE. | $91,898 | $91,898 | December 18, 2025 | May 31, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94025F00002 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (D5 GLYCEROL) FOR METABOLIC RESEARCH. | $81,715 | $81,715 | July 22, 2025 | April 30, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94025F00003 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE | $69,466 | $69,466 | August 14, 2025 | May 31, 2026 | Tonawanda, NY | usaspending.gov |
| 75N98026F00002 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK METABOLIC ISOTOPES | $54,487 | $54,487 | September 30, 2024 | September 29, 2029 | Tonawanda, NY | usaspending.gov |
| 75N98026F00001 | Department of Health and Human Services | Delivery Order | 325412 | 1. 26-003399 - IDIQ 75N94024D00003, SEND PO TO [email protected], DELIVERY BY 6/1/26; ORAL STABLE ISOTOPE-DEUTERIUM OXIDE, BI | $39,279 | $39,279 | April 21, 2026 | October 30, 2026 | Tonawanda, NY | usaspending.gov |
| 36C26325N0138 | Department of Veterans Affairs | Delivery Order | 325412 | 503B COMPOUNDING PHARMACEUTICALS | $37,715 | $37,715 | October 1, 2024 | September 30, 2025 | Tonawanda, NY | usaspending.gov |
| 36C26324N0478 | Department of Veterans Affairs | Delivery Order | 325412 | 503B COMPOUNDING PHARMACEUTICALS | $37,118 | $37,118 | February 7, 2024 | September 30, 2024 | Tonawanda, NY | usaspending.gov |
| 75N98C26P00019 | Department of Health and Human Services | Purchase Order | 325412 | ATORVASTATIN 40 MG CAPSULES AND PLACEBO CAPSULES, QTY 1,232 BATCH. | $24,652 | $24,652 | February 17, 2026 | February 16, 2027 | Tonawanda, NY | usaspending.gov |
| 36C26326N0200 | Department of Veterans Affairs | Delivery Order | 325412 | 503B COMPOUNDING PHARMACEUTICALS | $21,673 | $21,673 | October 1, 2025 | March 31, 2026 | Tonawanda, NY | usaspending.gov |
| 75N94024P00181 | Department of Health and Human Services | Purchase Order | 325414 | NIDDK / IV ISOTOPE 6,6 D2GLUCOSE | $15,400 | $15,400 | March 1, 2024 | June 1, 2024 | Tonawanda, NY | usaspending.gov |
| 75N94024F00001 | Department of Health and Human Services | Delivery Order | 325412 | NIDDK NON-SEVERABLE TASK ORDER 1 FOR METABOLIC ISOTOPES. | $15,000 | $15,000 | September 30, 2024 | September 29, 2029 | Tonawanda, NY | usaspending.gov |
| 75N94024D00003 | Department of Health and Human Services | IDC | 325412 | NIDDK METABOLIC ISOTOPES | $0 | $7,272,049 | September 30, 2024 | usaspending.gov | ||
| 36C26324D0042 | Department of Veterans Affairs | IDC | 325412 | 503B COMPOUNDING PHARMACEUTICALS | $0 | $136,915 | February 7, 2024 | usaspending.gov | ||
| 75N95022P00016 | Department of Health and Human Services | Purchase Order | 325412 | COMPOUNDING OF 10% POLYSORBATE-80 TO DILUTE TPM-001 INVESTIGATIONAL DRUG FOR TREATMENT OF PERITONEAL CANCER | $0 | $23,754 | December 14, 2021 | May 2, 2025 | Tonawanda, NY | usaspending.gov |
| 75N94022P00285 | Department of Health and Human Services | Purchase Order | 325414 | NIDDK - 6,6 D2-GLUCOSE 72.9 MG/ML (30 ML) VIAL | $-210 | $12,371 | March 30, 2022 | May 14, 2022 | Tonawanda, NY | usaspending.gov |
| 75N94021P00105 | Department of Health and Human Services | Purchase Order | 325412 | PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE (POTASSIUM PALMITATE U-13C) FOR METABOLIC RESEARCH | $-466 | $41,486 | January 5, 2021 | August 20, 2027 | Tonawanda, NY | usaspending.gov |
| 75N94023P00093 | Department of Health and Human Services | Purchase Order | 325412 | INTRAVENOUS STABLE ISOTOPES (6,6-D2 GLUCOSE) FOR METABOLIC RESEARCH [23-000014] | $-479 | $138,712 | January 1, 2023 | March 30, 2023 | Tonawanda, NY | usaspending.gov |
| 75N94021P00376 | Department of Health and Human Services | Purchase Order | 325414 | NIDDK - D5 GLYCEROL--3 BATCHES/SHIPMENTS OF 60 EACH | $-1,782 | $27,385 | May 4, 2021 | May 4, 2022 | Tonawanda, NY | usaspending.gov |
| 75N90020P00581 | Department of Health and Human Services | Purchase Order | 325412 | STORAGE AND STABILITY TESTING BY PINE PHARMACEUTICALS, LLC:1270808 [POTS: 20-011114] | $-3,005 | $0 | September 9, 2020 | September 8, 2021 | Tonawanda, NY | usaspending.gov |
| 75N94020P00796 | Department of Health and Human Services | Purchase Order | 325412 | NIDDK: U13-C POTASSIUM PALMITATE | $-41,953 | $0 | September 18, 2020 | December 31, 2020 | Bethesda, MD | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- All recipients under NAICS 325199 All Other Basic Organic Chemical Manufacturing
- All recipients under NAICS 339112 Surgical and Medical Instrument Manufacturing
- Open opportunities under NAICS 325412
- Open opportunities under NAICS 325199
- Open opportunities under NAICS 339112
Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.